{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:18:13Z","timestamp":1778620693463,"version":"3.51.4"},"reference-count":100,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073659"],"award-info":[{"award-number":["82073659"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY21H020001"],"award-info":[{"award-number":["LY21H020001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.hrthm.2023.04.021","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T12:29:31Z","timestamp":1682684971000},"page":"1169-1177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Deciphering HERG mutation in long QT syndrome type 2 using antisense oligonucleotide\u2013mediated techniques: Lessons from cystic fibrosis"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5166-2528","authenticated-orcid":false,"given":"Zequn","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongfei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuerui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2023.04.021_bib1","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/europace\/euac030","article-title":"European Heart Rhythm Association (EHRA)\/Heart Rhythm Society (HRS)\/Asia Pacific Heart Rhythm Society (APHRS)\/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases","volume":"24","author":"Wilde","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2023.04.021_bib2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/europace\/euab238","article-title":"Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)","volume":"24","author":"Mazzanti","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2023.04.021_bib3","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/eurheartj\/ehz023","article-title":"From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome type 2","volume":"40","author":"Schwartz","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2023.04.021_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-020-0188-7","article-title":"Inherited cardiac arrhythmias","volume":"6","author":"Schwartz","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.hrthm.2023.04.021_bib5","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3390\/biom10081144","article-title":"Long QT syndrome type 2: emerging strategies for correcting class 2 KCNH2 (hERG) mutations and identifying new patients","volume":"10","author":"Ono","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.hrthm.2023.04.021_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.joa.2015.11.009","article-title":"Molecular pathogenesis of long QT syndrome type 2","volume":"32","author":"Smith","year":"2016","journal-title":"J Arrhythm"},{"key":"10.1016\/j.hrthm.2023.04.021_bib7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0092-8674(95)90358-5","article-title":"A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome","volume":"80","author":"Curran","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.hrthm.2023.04.021_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.107.708818","article-title":"Nonsense mutations in hERG cause a decrease in mutant mRNA transcripts by nonsense-mediated mRNA decay in human long-QT syndrome","volume":"116","author":"Gong","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2023.04.021_bib9","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1161\/01.RES.0000128561.28701.ea","article-title":"Biology of cardiac arrhythmias: ion channel protein trafficking","volume":"94","author":"Delisle","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2023.04.021_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tcb.2008.04.005","article-title":"The meaning of nonsense","volume":"18","author":"Stalder","year":"2008","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.hrthm.2008.01.020","article-title":"Recurrent intrauterine fetal loss due to near absence of HERG: clinical and functional characterization of a homozygous nonsense HERG Q1070X mutation","volume":"5","author":"Bhuiyan","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2023.04.021_bib12","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.hrthm.2011.03.039","article-title":"Nonsense-mediated mRNA decay caused by a frameshift mutation in a large kindred of type 2 long QT syndrome","volume":"8","author":"Zarraga","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2023.04.021_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.yjmcc.2010.10.022","article-title":"Inhibition of nonsense-mediated mRNA decay by antisense morpholino oligonucleotides restores functional expression of hERG nonsense and frameshift mutations in long-QT syndrome","volume":"50","author":"Gong","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13073-015-0223-6","article-title":"Targeted therapies to improve CFTR function in cystic fibrosis","volume":"7","author":"Brodlie","year":"2015","journal-title":"Genome Med"},{"key":"10.1016\/j.hrthm.2023.04.021_bib15","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/eurheartj\/ehx394","article-title":"Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model","volume":"39","author":"Mehta","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2023.04.021_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1172-8-11","article-title":"Compounds that correct F508del-CFTR trafficking can also correct other protein trafficking diseases: an in\u00a0vitro study using cell lines","volume":"8","author":"Sampson","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.hrthm.2023.04.021_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/164_2019_333","article-title":"Exploiting the diversity of ion channels: modulation of ion channels for therapeutic indications","volume":"260","author":"Liu","year":"2019","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1242\/dmm.014001","article-title":"The role of the cytosolic HSP70 chaperone system in diseases caused by misfolding and aberrant trafficking of ion channels","volume":"7","author":"Young","year":"2014","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.hrthm.2023.04.021_bib19","first-page":"7454","article-title":"Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells","volume":"48","author":"Michaels","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.hrthm.2023.04.021_bib20","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.ymthe.2019.06.016","article-title":"Steric inhibition of 5\u02b9 UTR regulatory elements results in upregulation of human CFTR","volume":"27","author":"Sasaki","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.hrthm.2023.04.021_bib21","article-title":"Exon-skipping antisense oligonucleotides for cystic fibrosis therapy","volume":"119","author":"Kim","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hrthm.2023.04.021_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2114886119","article-title":"Open reading frame correction using splice-switching antisense oligonucleotides for the treatment of cystic fibrosis","volume":"119","author":"Michaels","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hrthm.2023.04.021_bib23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41580-019-0126-2","article-title":"Quality and quantity control of gene expression by nonsense-mediated mRNA decay","volume":"20","author":"Kurosaki","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib24","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/eurheartj\/ehab007","article-title":"Precision medicine and cardiac channelopathies: when dreams meet reality","volume":"42","author":"Gnecchi","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2023.04.021_bib25","doi-asserted-by":"crossref","first-page":"15037","DOI":"10.1073\/pnas.1300654110","article-title":"Inhibition of SMG-8, a subunit of SMG-1 kinase, ameliorates nonsense-mediated mRNA decay-exacerbated mutant phenotypes without cytotoxicity","volume":"110","author":"Usuki","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hrthm.2023.04.021_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13059-017-1386-9","article-title":"Antisense suppression of the nonsense mediated decay factor Upf3b as a potential treatment for diseases caused by nonsense mutations","volume":"19","author":"Huang","year":"2018","journal-title":"Genome Biol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib27","doi-asserted-by":"crossref","first-page":"a032862","DOI":"10.1101\/cshperspect.a032862","article-title":"Nonsense-mediated mRNA decay begins where translation ends","volume":"11","author":"Karousis","year":"2019","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.tig.2020.08.010","article-title":"The branched nature of the nonsense-mediated mRNA decay pathway","volume":"37","author":"Yi","year":"2021","journal-title":"Trends Genet"},{"key":"10.1016\/j.hrthm.2023.04.021_bib29","doi-asserted-by":"crossref","first-page":"7600","DOI":"10.1093\/nar\/gkv668","article-title":"A network of SMG-8, SMG-9 and SMG-1 C-terminal insertion domain regulates UPF1 substrate recruitment and phosphorylation","volume":"43","author":"Deniaud","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.hrthm.2023.04.021_bib30","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1101\/gad.1767209","article-title":"SMG-8 and SMG-9, two novel subunits of the SMG-1 complex, regulate remodeling of the mRNA surveillance complex during nonsense-mediated mRNA decay","volume":"23","author":"Yamashita","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.hrthm.2023.04.021_bib31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/nar\/gkq749","article-title":"Characterization of SMG-9, an essential component of the nonsense-mediated mRNA decay SMG1C complex","volume":"39","author":"Fern\u00e1ndez","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.hrthm.2023.04.021_bib32","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41422-019-0255-3","article-title":"Cryo-EM structure of SMG1-SMG8-SMG9 complex","volume":"29","author":"Zhu","year":"2019","journal-title":"Cell Res"},{"key":"10.1016\/j.hrthm.2023.04.021_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nsmb1330","article-title":"NMD factors UPF2 and UPF3 bridge UPF1 to the exon junction complex and stimulate its RNA helicase activity","volume":"15","author":"Chamieh","year":"2008","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.molcel.2011.02.010","article-title":"Molecular mechanisms for the RNA-dependent ATPase activity of Upf1 and its regulation by Upf2","volume":"41","author":"Chakrabarti","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.hrthm.2023.04.021_bib35","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S1097-2765(03)00349-6","article-title":"Nonsense-mediated mRNA decay in mammalian cells involves decapping, deadenylating, and exonucleolytic activities","volume":"12","author":"Lejeune","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.hrthm.2023.04.021_bib36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0968-0004(98)01208-0","article-title":"A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance","volume":"23","author":"Nagy","year":"1998","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.hrthm.2023.04.021_bib37","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1261\/rna.076687.120","article-title":"Viral subversion of nonsense-mediated mRNA decay","volume":"26","author":"Popp","year":"2020","journal-title":"RNA"},{"key":"10.1016\/j.hrthm.2023.04.021_bib38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-genet-111212-133424","article-title":"Organizing principles of mammalian nonsense-mediated mRNA decay","volume":"47","author":"Popp","year":"2013","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.hrthm.2023.04.021_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI0214841","article-title":"Killing the messenger: new insights into nonsense-mediated mRNA decay","volume":"109","author":"Byers","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hrthm.2023.04.021_bib41","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.3390\/ijms23137389","article-title":"Mutation-specific differences in Kv7.1 (KCNQ1) and Kv11.1 (KCNH2) channel dysfunction and long QT syndrome phenotypes","volume":"23","author":"Kekenes-Huskey","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hrthm.2023.04.021_bib42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/0929867324666170718101946","article-title":"NGS technologies as a turning point in rare disease research, diagnosis and treatment","volume":"25","author":"Fernandez-Marmiesse","year":"2018","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.hrthm.2023.04.021_bib43","article-title":"What is the potential for lumacaftor as a chemical chaperone in promoting hERG trafficking?","volume":"9","author":"Zheng","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2023.04.021_bib44","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00232-013-9539-6","article-title":"Mechanistic basis for type 2 long QT syndrome caused by KCNH2 mutations that disrupt conserved arginine residues in the voltage sensor","volume":"246","author":"McBride","year":"2013","journal-title":"J Membr Biol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib45","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1161\/CIRCULATIONAHA.112.118018","article-title":"Mechanism of loss of Kv11.1 K+ current in mutant T421M-Kv11.1-expressing rat ventricular myocytes: interaction of trafficking and gating","volume":"126","author":"Balijepalli","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2023.04.021_bib46","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1113\/JP271805","article-title":"Rescue of protein expression defects may not be enough to abolish the pro-arrhythmic phenotype of long QT type 2 mutations","volume":"594","author":"Perry","year":"2016","journal-title":"J Physiol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4939-7362-0_4","article-title":"Nonsense-mediated mRNA decay of hERG mutations in long QT syndrome","volume":"1684","author":"Gong","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib48","doi-asserted-by":"crossref","first-page":"H1397","DOI":"10.1152\/ajpheart.00304.2013","article-title":"LQT2 nonsense mutations generate trafficking defective NH2-terminally truncated channels by the reinitiation of translation","volume":"305","author":"Stump","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib49","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.febslet.2005.02.047","article-title":"Are splicing mutations the most frequent cause of hereditary disease?","volume":"579","author":"L\u00f3pez-Bigas","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.hrthm.2023.04.021_bib50","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.molcel.2018.07.033","article-title":"Quantitative activity profile and context dependence of all human 5\u02b9 splice sites","volume":"71","author":"Wong","year":"2018","journal-title":"Mol Cell"},{"key":"10.1016\/j.hrthm.2023.04.021_bib51","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tig.2018.10.002","article-title":"RNA splicing and disease: animal models to therapies","volume":"35","author":"Montes","year":"2019","journal-title":"Trends Genet"},{"key":"10.1016\/j.hrthm.2023.04.021_bib52","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.tips.2018.09.001","article-title":"Precision medicine through antisense oligonucleotide-mediated exon skipping","volume":"39","author":"Li","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.hrthm.2023.04.021_bib53","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/14017430802582610","article-title":"A novel nonsense mutation Y652X in the S6\/pore region of human ether-go-go gene found in a long QT syndrome family","volume":"43","author":"Sun","year":"2009","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.hrthm.2023.04.021_bib54","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.yjmcc.2012.08.021","article-title":"Early LQT2 nonsense mutation generates N-terminally truncated hERG channels with altered gating properties by the reinitiation of translation","volume":"53","author":"Stump","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib55","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.gene.2014.02.012","article-title":"Position of premature termination codons determines susceptibility of hERG mutations to nonsense-mediated mRNA decay in long QT syndrome","volume":"539","author":"Gong","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.hrthm.2023.04.021_bib56","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3390\/ph15080909","article-title":"The medicinal chemistry of artificial nucleic acids and therapeutic oligonucleotides","volume":"15","author":"Bege","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.hrthm.2023.04.021_bib57","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1080\/17425255.2021.1992382","article-title":"Antisense oligonucleotides: absorption, distribution, metabolism, and excretion","volume":"17","author":"Shadid","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib58","doi-asserted-by":"crossref","first-page":"9645","DOI":"10.1021\/acs.jmedchem.6b00551","article-title":"The medicinal chemistry of therapeutic oligonucleotides","volume":"59","author":"Wan","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.hrthm.2023.04.021_bib59","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1038\/s41467-022-30668-y","article-title":"Gene-specific nonsense-mediated mRNA decay targeting for cystic fibrosis therapy","volume":"13","author":"Kim","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.hrthm.2023.04.021_bib60","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fphar.2019.00488","article-title":"Enhanced inhibition of tumorigenesis using combinations of miRNA-targeted therapeutics","volume":"10","author":"Miroshnichenko","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib61","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207956119","article-title":"Thiomorpholino oligonucleotides as a robust class of next generation platforms for alternate mRNA splicing","volume":"119","author":"Le","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hrthm.2023.04.021_bib62","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/nar\/gkad067","article-title":"Chemistry, structure and function of approved oligonucleotide therapeutics","volume":"51","author":"Egli","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.hrthm.2023.04.021_bib63","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1101\/gad.913001","article-title":"Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay","volume":"15","author":"Yamashita","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.hrthm.2023.04.021_bib64","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ymthe.2006.04.011","article-title":"Specific inhibition of nonsense-mediated mRNA decay components, SMG-1 or Upf1, rescues the phenotype of Ullrich disease fibroblasts","volume":"14","author":"Usuki","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.hrthm.2023.04.021_bib65","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1165\/rcmb.2018-0316OC","article-title":"Nonsense-mediated RNA decay pathway inhibition restores expression and function of W1282X CFTR","volume":"61","author":"Keenan","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib66","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.neuron.2019.08.027","article-title":"Inhibition of Upf2-dependent nonsense-mediated decay leads to behavioral and neurophysiological abnormalities by activating the immune response","volume":"104","author":"Johnson","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.hrthm.2023.04.021_bib67","doi-asserted-by":"crossref","first-page":"12186","DOI":"10.1073\/pnas.1007336107","article-title":"Smg1 is required for embryogenesis and regulates diverse genes via alternative splicing coupled to nonsense-mediated mRNA decay","volume":"107","author":"McIlwain","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hrthm.2023.04.021_bib68","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/s41467-022-29935-9","article-title":"CFTR mRNAs with nonsense codons are degraded by the SMG6-mediated endonucleolytic decay pathway","volume":"13","author":"Sanderlin","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.hrthm.2023.04.021_bib69","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.cell.2016.10.050","article-title":"Exon skipping therapy","volume":"167","author":"Young","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.hrthm.2023.04.021_bib70","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/bfgp\/elr020","article-title":"RNA splicing: disease and therapy","volume":"10","author":"Douglas","year":"2011","journal-title":"Brief Funct Genomics"},{"key":"10.1016\/j.hrthm.2023.04.021_bib71","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-4939-7374-3_10","article-title":"Designing effective antisense oligonucleotides for exon skipping","volume":"1687","author":"Shimo","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib72","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1093\/nar\/gki810","article-title":"Distribution of SR protein exonic splicing enhancer motifs in human protein-coding genes","volume":"33","author":"Wang","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.hrthm.2023.04.021_bib73","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-4939-8651-4_5","article-title":"Tips to design effective splice-switching antisense oligonucleotides for exon skipping and exon inclusion","volume":"1828","author":"Maruyama","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib74","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.bpj.2013.09.053","article-title":"S3-S4 linker length modulates the relaxed state of a voltage-gated potassium channel","volume":"105","author":"Priest","year":"2013","journal-title":"Biophys J"},{"key":"10.1016\/j.hrthm.2023.04.021_bib75","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cell.2017.03.048","article-title":"Cryo-EM structure of the open human ether-\u00e0-go-go-related K+ channel hERG","volume":"169","author":"Wang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.hrthm.2023.04.021_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016191","article-title":"The N-terminal tail of hERG contains an amphipathic \u03b1-helix that regulates channel deactivation","volume":"6","author":"Ng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2023.04.021_bib77","doi-asserted-by":"crossref","first-page":"13782","DOI":"10.1074\/jbc.M113.531277","article-title":"Role of the cytoplasmic N-terminal Cap and Per-Arnt-Sim (PAS) domain in trafficking and stabilization of Kv11.1 channels","volume":"289","author":"Ke","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hrthm.2023.04.021_bib78","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1021\/ci4000739","article-title":"Interactions between voltage sensor and pore domains in a hERG K+ channel model from molecular simulations and the effects of a voltage sensor mutation","volume":"53","author":"Colenso","year":"2013","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.hrthm.2023.04.021_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.687007","article-title":"Molecular insights into the gating kinetics of the cardiac hERG channel, illuminated by structure and molecular dynamics","volume":"12","author":"Zequn","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib80","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4161\/chan.1.6.5760","article-title":"Differences between ion binding to eag and HERG voltage sensors contribute to differential regulation of activation and deactivation gating","volume":"1","author":"Lin","year":"2007","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.hrthm.2023.04.021_bib81","doi-asserted-by":"crossref","first-page":"7688","DOI":"10.1074\/jbc.M117.779298","article-title":"The S1 helix critically regulates the finely tuned gating of Kv11.1 channels","volume":"292","author":"Phan","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hrthm.2023.04.021_bib82","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.jacc.2009.08.028","article-title":"Genotype-phenotype aspects of type 2 long QT syndrome","volume":"54","author":"Shimizu","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib83","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1261\/rna.653607","article-title":"Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications","volume":"13","author":"Aartsma-Rus","year":"2007","journal-title":"RNA"},{"key":"10.1016\/j.hrthm.2023.04.021_bib85","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1021\/acs.bioconjchem.8b00761","article-title":"Bioconjugated oligonucleotides: recent developments and therapeutic applications","volume":"30","author":"Benizri","year":"2019","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.hrthm.2023.04.021_bib86","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.hrthm.2023.04.021_bib87","doi-asserted-by":"crossref","first-page":"11401","DOI":"10.1093\/nar\/gkac641","article-title":"Enhanced exon skipping and prolonged dystrophin restoration achieved by TfR1-targeted delivery of antisense oligonucleotide using FORCE conjugation in mdx mice","volume":"50","author":"Desjardins","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.hrthm.2023.04.021_bib88","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1038\/s41467-022-31636-2","article-title":"An LNA-amide modification that enhances the cell uptake and activity of phosphorothioate exon-skipping oligonucleotides","volume":"13","author":"Baker","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.hrthm.2023.04.021_bib89","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3727\/096368916X690863","article-title":"Allele-specific reduction of the mutant huntingtin allele using transcription activator-like effectors in human Huntington\u2019s disease fibroblasts","volume":"25","author":"Fink","year":"2016","journal-title":"Cell Transplant"},{"key":"10.1016\/j.hrthm.2023.04.021_bib90","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCULATIONAHA.105.570200","article-title":"Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism","volume":"113","author":"Anderson","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2023.04.021_bib91","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.ajhg.2022.05.003","article-title":"A massively parallel assay accurately discriminates between functionally normal and abnormal variants in a hotspot domain of KCNH2","volume":"109","author":"Ng","year":"2022","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hrthm.2023.04.021_bib92","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1038\/ncomms6535","article-title":"Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome","volume":"5","author":"Anderson","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.hrthm.2023.04.021_bib93","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/europace\/euac269","article-title":"Non-missense variants of KCNH2 show better outcomes in type 2 long QT syndrome","volume":"25","author":"Aizawa","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2023.04.021_bib94","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1540-8167.2009.01468.x","article-title":"Not all hERG pore domain mutations have a severe phenotype: G584S has an inactivation gating defect with mild phenotype compared to G572S, which has a dominant negative trafficking defect and a severe phenotype","volume":"20","author":"Zhao","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib95","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/aps.2014.101","article-title":"Translational toxicology and rescue strategies of the hERG channel dysfunction: biochemical and molecular mechanistic aspects","volume":"35","author":"Zhang","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.hrthm.2023.04.021_bib96","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/hmg\/ddz028","article-title":"Nonsense-mediated mRNA decay efficiency varies in choroideremia providing a target to boost small molecule therapeutics","volume":"28","author":"Sarkar","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hrthm.2023.04.021_bib97","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nbt.3427","article-title":"Antisense oligonucleotide-directed inhibition of nonsense-mediated mRNA decay","volume":"34","author":"Nomakuchi","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib98","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1085\/jgp.200308788","article-title":"Negative charges in the transmembrane domains of the HERG K channel are involved in the activation- and deactivation-gating processes","volume":"121","author":"Liu","year":"2003","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib99","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00424-018-2135-y","article-title":"Functional characterization of Kv11.1 (hERG) potassium channels split in the voltage-sensing domain","volume":"470","author":"de la Pe\u00f1a","year":"2018","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.hrthm.2023.04.021_bib100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.yjmcc.2012.06.011","article-title":"Deciphering hERG channels: molecular basis of the rapid component of the delayed rectifier potassium current","volume":"53","author":"Jonsson","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hrthm.2023.04.021_bib101","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13046-020-01798-2","article-title":"Noncoding RNAs regulate alternative splicing in cancer","volume":"40","author":"Liu","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.hrthm.2023.04.021_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102233","article-title":"The N-linker region of hERG1a upregulates hERG1b potassium channels","volume":"298","author":"Johnson","year":"2022","journal-title":"J Biol Chem"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154752712302180X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154752712302180X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:31:40Z","timestamp":1778617900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154752712302180X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":100,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S154752712302180X"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2023.04.021","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering HERG mutation in long QT syndrome type 2 using antisense oligonucleotide\u2013mediated techniques: Lessons from cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2023.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}